Caisse de Depot et Placement du Quebec (CDPQ)’s Charles River Laboratories CRL Stock Holding History

Caisse de Depot et Placement du Quebec (CDPQ)’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-40,377	Closed	-$6.97M	–	718
2026 Q1	$6.97M	Buy	+40,377	New	+$7.49M	0.01%	471
2025 Q4	–	Sell	-14,000	Closed	-$2.19M	–	557
2025 Q3	$2.19M	Buy	+14,000	New	+$2.22M	﹤0.01%	500
2025 Q2	–	Sell	-85,000	Closed	-$12.8M	–	515
2025 Q1	$12.8M	Buy	+85,000	New	+$14.3M	0.03%	357
2023 Q4	–	Sell	-14,500	Closed	-$2.84M	–	492
2023 Q3	$2.84M	Buy	+14,500	New	+$2.98M	0.01%	372
2022 Q2	–	Sell	-7,800	Closed	-$2.21M	–	602
2022 Q1	$2.21M	Buy	7,800 +100	+1%	+$30.8K	0.01%	498
2021 Q4	$2.9M	Buy	7,700 +6,200	+413%	+$2.41M	0.01%	433
2021 Q3	$619K	Buy	1,500 +100	+7%	+$41.5K	﹤0.01%	489
2021 Q2	$518K	Buy	+1,400	New	+$467K	﹤0.01%	469
2018 Q1	–	Sell	-40,000	Closed	-$4.38M	–	736
2017 Q4	$4.38M	Buy	+40,000	New	+$4.35M	0.01%	379

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ)'s CRL Position: Q2 2026 in Review

Caisse de Depot et Placement du Quebec (CDPQ) sold out of Charles River Laboratories (CRL) in Q2 2026, closing a stake of 40,377 shares — an estimated $6.97M sold.

Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in CRL in Q4 2017 and held it in 9 quarters. The position peaked at $12.8M in Q1 2025. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

Caisse de Depot et Placement du Quebec (CDPQ) reported no remaining Charles River Laboratories position as of Q2 2026 after selling out during the quarter.
Caisse de Depot et Placement du Quebec (CDPQ) sold 40,377 Charles River Laboratories shares in Q2 2026, an estimated $6.97M.
Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in Charles River Laboratories in Q4 2017 and held it in 9 quarters.
Caisse de Depot et Placement du Quebec (CDPQ)'s Charles River Laboratories position peaked at $12.8M in Q1 2025.
570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Caisse de Depot et Placement du Quebec (CDPQ)'s 13F filing for Q2 2026, filed 14 Aug 2026.